CMMB Latest Press Releases, Chemomab Therapeutics Ltd Corporate News

Releases

0.7000

+18.64%

0.1100

All
Financials
Insiders

20-F | Chemomab Therapeutics Ltd.(0001534248)
Mar 28,2024 06:18
SC 13D/A | Chemomab Therapeutics Ltd.(0001534248)
Mar 11,2024 19:20
6-K | Chemomab Therapeutics Ltd.(0001534248)
Mar 07,2024 07:01
6-K | Chemomab Therapeutics Ltd.(0001534248)
Jan 03,2024 07:01
CORRESP | Chemomab Therapeutics Ltd.(0001534248)
Dec 05,2023 09:55
SC 13D/A | Chemomab Therapeutics Ltd.(0001534248)
Nov 15,2023 16:36
6-K | Chemomab Therapeutics Ltd.(0001534248)
Nov 09,2023 08:01
EFFECT | Chemomab Therapeutics Ltd.(0001534248)
Nov 06,2023 06:07
F-3/A | Chemomab Therapeutics Ltd.(0001534248)
Oct 30,2023 08:34
F-3 | Chemomab Therapeutics Ltd.(0001534248)
Oct 16,2023 16:26
6-K | Chemomab Therapeutics Ltd.(0001534248)
Aug 14,2023 08:07
6-K | Chemomab Therapeutics Ltd.(0001534248)
Aug 08,2023 06:09
4 | Chemomab Therapeutics Ltd.(0001534248)
Jul 05,2023 17:50
6-K | Chemomab Therapeutics Ltd.(0001534248)
Jul 03,2023 15:50
4 | Chemomab Therapeutics Ltd. (0001534248)
Jun 20,2023 06:03
4 | Chemomab Therapeutics Ltd.(0001534248)
Jun 16,2023 16:04
8-K | Chemomab Therapeutics Ltd.(0001534248)
Jun 16,2023 16:03
3 | Chemomab Therapeutics Ltd.(0001534248)
Jun 05,2023 17:07
8-K | Chemomab Therapeutics Ltd.(0001534248)
Jun 05,2023 07:01
RW | Chemomab Therapeutics Ltd.(0001534248)
Jun 02,2023 16:03
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
May 19,2023 16:08
8-K | Chemomab Therapeutics Ltd.(0001534248)
May 11,2023 06:12
10-Q | Chemomab Therapeutics Ltd.(0001534248)
May 11,2023 06:09
4 | Chemomab Therapeutics Ltd.(0001534248)
Mar 23,2023 07:39
4 | Chemomab Therapeutics Ltd.(0001534248)
Mar 23,2023 07:38
4 | Chemomab Therapeutics Ltd.(0001534248)
Mar 23,2023 07:36
4 | Chemomab Therapeutics Ltd.(0001534248)
Mar 23,2023 07:34
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
Mar 22,2023 16:46
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
Mar 21,2023 16:12
10-K | Chemomab Therapeutics Ltd.(0001534248)
Mar 20,2023 06:24
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
Feb 22,2023 06:05
8-K | Chemomab Therapeutics Ltd.(0001534248)
Feb 21,2023 07:06
S-1/A | Chemomab Therapeutics Ltd.(0001534248)
Feb 21,2023 06:21
8-K | Chemomab Therapeutics Ltd.(0001534248)
Feb 21,2023 06:13
S-1 | Chemomab Therapeutics Ltd.(0001534248)
Jan 13,2023 16:03
8-K | Chemomab Therapeutics Ltd.(0001534248)
Jan 11,2023 16:03
4 | Chemomab Therapeutics Ltd.(0001534248)
Jan 05,2023 16:50
SC 13D/A | Chemomab Therapeutics Ltd.(0001534248)
Jan 05,2023 16:33
4 | Chemomab Therapeutics Ltd.(0001534248)
Jan 05,2023 16:02
8-K | Chemomab Therapeutics Ltd.(0001534248)
Jan 03,2023 07:07
8-K/A | Chemomab Therapeutics Ltd.(0001534248)
Nov 29,2022 06:22
4 | Chemomab Therapeutics Ltd.(0001534248)
Nov 18,2022 07:58
4 | Chemomab Therapeutics Ltd.(0001534248)
Nov 17,2022 16:58
SC 13D/A | Chemomab Therapeutics Ltd.(0001534248)
Nov 17,2022 16:49
8-K | Chemomab Therapeutics Ltd.(0001534248)
Nov 16,2022 07:29
3 | Chemomab Therapeutics Ltd.(0001534248)
Nov 15,2022 16:12
8-K | Chemomab Therapeutics Ltd.(0001534248)
Nov 14,2022 16:20
10-Q | Chemomab Therapeutics Ltd.(0001534248)
Nov 10,2022 16:20
S-8 | Chemomab Therapeutics Ltd.(0001534248)
Aug 15,2022 16:13
10-Q | Chemomab Therapeutics Ltd.(0001534248)
Aug 12,2022 07:39

Webull provides the latest Chemomab Therapeutics Ltd (CMMB) stock and general news. This information may help you make smarter investment decisions.

About CMMB

Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.